US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Agenus

4.79

+0.15003.23%

Post-market: 4.790.00000.00%19:32 EDT

Volume:827.40K

Turnover:3.86M

Market Cap:183.93M

PE:-1.41K

High:4.80

Open:4.70

Low:4.52

Close:4.64

52wk High:7.34

52wk Low:1.96

Shares:38.40M

Float Shares:35.64M

Volume Ratio:0.50

T/O Rate:2.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0034

EPS(LYR):-10.5913

ROE:-1278.83%

ROA:-5.67%

PB:-0.68

PE(LYR):-0.45

Loading ...

Overview Company News Filings

Agenus reports Phase 2 results from BOT and BAL with agenT-797

BRIEF-Agenus Reports Phase Ii Data Demonstrating Immune Reprogramming And Durable Survival With Botensilimab, Balstilimab And Agent-797 In Pd-1 Refractory Gastroesophageal Cancer

Agenus reports Phase II data showing 77% disease control in PD-1 refractory gastroesophageal cancer

Agenus Inc - Study Does Not Meet Primary Endpoint of Objective Response Rate

THOMSON REUTERS

Agenus to present Phase II BOT+BAL plus agenT-797 data in PD-1 refractory GEC at AACR

Agenus Announces Data From Phase Ii Study of BOT+Bal in Combination With Agent-797 in Pd-1 Refractory Gastroesophageal Cancer to Be Presented at Aacr 2026

THOMSON REUTERS

Agenus Says First Patient Enrolled in Phase 3 Colorectal Cancer Trial

MT Newswires Live

Agenus enrolls first patient in Phase 3 BATTMAN trial for BOT+BAL in MSS mCRC

Agenus Announces First Patient Enrolled in Global Phase 3 Battman Trial of BOT+Bal Immunotherapy Combination in Mss or Pmmr Metastatic Colorectal Cancer

THOMSON REUTERS

Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating

Agenus to host stakeholder webcast on BOT+BAL immunotherapy program; Q&A to follow live session

Agenus securities class action dismissed in full; Massachusetts federal court denies leave to amend

Mink Therapeutics names Melissa Orilall principal financial officer and Austin Charette principal accounting officer

Agenus (AGEN) Q3 Profit Of US$63.9 Million Tests Longstanding Loss-Making Narrative

Simply Wall St.

Agenus to present preliminary BOT+BAL first-line MSS metastatic colorectal cancer data at AACR 2026

Agenus Inc reports results for the quarter ended December 31 - Earnings Summary

Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating

Agenus Q4 2025 other revenue rose 87.8% to USD 31.1 million as net loss totaled USD 10.6 million

Press Release: Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

Calendar of U.S. Earnings Expected in the Week Ahead

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AGEN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","market":"US","secType":"STK","nameCN":"Agenus","latestPrice":4.79,"timestamp":1776456000000,"preClose":4.64,"halted":0,"volume":827402,"hourTrading":{"tag":"盘后","latestPrice":4.79,"preClose":4.79,"latestTime":"19:32 EDT","volume":32829,"amount":151097.575,"timestamp":1776468779702,"change":0,"changeRate":0,"amplitude":0.106472},"delay":0,"changeRate":0.03232758620689663,"floatShares":35642200,"shares":38398354,"eps":-0.003396,"marketStatus":"Market Closed","change":0.15,"latestTime":"04-17 16:00:00 EDT","open":4.7,"high":4.8,"low":4.52,"amount":3860660.0487256004,"amplitude":0.060345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003396,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":949640400000,"exchange":"NASDAQ","adjPreClose":4.64,"preHourTrading":{"tag":"盘前","latestPrice":4.66,"preClose":4.64,"latestTime":"09:05 EDT","volume":1140,"amount":5385.227304,"timestamp":1776431147637,"change":0.02,"changeRate":0.00431,"amplitude":0.015086},"postHourTrading":{"tag":"盘后","latestPrice":4.79,"preClose":4.79,"latestTime":"19:32 EDT","volume":32829,"amount":151097.575,"timestamp":1776468779702,"change":0,"changeRate":0,"amplitude":0.106472},"volumeRatio":0.49591774048298465,"impliedVol":1.0498,"impliedVolPercentile":0.632},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","floatShares":35642200,"roa":"-5.67%","roe":"-1278.83%","lyrEps":-10.5913,"volumeRatio":0.49591774048298465,"shares":38398354,"dividePrice":0,"high":4.8,"amplitude":0.060345,"preClose":4.64,"low":4.52,"week52Low":1.96,"pbRate":"-0.68","psRate":"1.61","week52High":7.34,"institutionHeld":0.0265,"latestPrice":4.79,"eps":-0.003396,"divideRate":0,"volume":827402,"delay":0,"ttmEps":-0.003396,"open":4.7,"prevYearClose":3.14,"prevWeekClose":3.96,"prevMonthClose":3.34,"prevQuarterClose":3.34,"fiveDayClose":3.96,"twentyDayClose":3.81,"sixtyDayClose":3.4,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"AGEN","fiscalQuarterEnding":"2025/12","expectedEps":-1.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2025-11-10","symbol":"AGEN","fiscalQuarterEnding":"2025/09","expectedEps":2.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":1.94},{"market":"US","date":"2025-08-11","symbol":"AGEN","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":1},{"market":"US","date":"2025-05-12","symbol":"AGEN","fiscalQuarterEnding":"2025/03","expectedEps":-1.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-11","symbol":"AGEN","fiscalQuarterEnding":"2024/12","expectedEps":-2.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-2.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGEN\",market:\"US\",,,undefined,":[{"executeDate":"2023-04-26","recordDate":"2023-04-17","paymentDate":"2023-05-01","value":0.0146,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1749096000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGEN","date":"2026-04-17","current":-1410.482921,"percent":0.998347,"low":-44.01113,"twenty":-4.177787,"median":-1.132758,"eighty":-0.342131,"high":1612.730861,"avg":33.512324,"sd":178.652208,"marketCap":178168362},"quantilePoints":[{"date":"2021-04-23","current":-3.450759,"twenty":-4.561481,"median":-3.742286,"eighty":-2.831819,"marketCap":624290537},{"date":"2021-04-30","current":-3.799279,"twenty":-4.547596,"median":-3.732192,"eighty":-2.831819,"marketCap":687342717},{"date":"2021-05-07","current":-3.595749,"twenty":-4.534042,"median":-3.718267,"eighty":-2.831819,"marketCap":682893897},{"date":"2021-05-14","current":-3.78315,"twenty":-4.517345,"median":-3.712607,"eighty":-2.831819,"marketCap":718484459},{"date":"2021-05-21","current":-4.907553,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":932027827},{"date":"2021-05-28","current":-4.989541,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":947598698},{"date":"2021-06-04","current":-4.720153,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":896437266},{"date":"2021-06-11","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-06-18","current":-6.160795,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1170039707},{"date":"2021-06-25","current":-6.289633,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1194508218},{"date":"2021-07-02","current":-6.465321,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1227874369},{"date":"2021-07-09","current":-6.605871,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1254567290},{"date":"2021-07-16","current":-6.313058,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1198957038},{"date":"2021-07-23","current":-6.582446,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1250118470},{"date":"2021-07-30","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-08-06","current":-6.594159,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1252342880},{"date":"2021-08-13","current":-6.351279,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1433655066},{"date":"2021-08-20","current":-6.248006,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1410343602},{"date":"2021-08-27","current":-6.464879,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1459297677},{"date":"2021-09-03","current":-6.289315,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1419668188},{"date":"2021-09-10","current":-6.712733,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1515245192},{"date":"2021-09-17","current":-6.020806,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1359058380},{"date":"2021-09-24","current":-6.093097,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1375376405},{"date":"2021-10-01","current":-5.494114,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1240169911},{"date":"2021-10-08","current":-5.907205,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1333415769},{"date":"2021-10-15","current":-5.483787,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1237838764},{"date":"2021-10-22","current":-4.14124,"twenty":-4.510274,"median":-3.714145,"eighty":-2.836115,"marketCap":934789726},{"date":"2021-10-29","current":-3.965676,"twenty":-4.491197,"median":-3.714145,"eighty":-2.836115,"marketCap":895160236},{"date":"2021-11-05","current":-4.296149,"twenty":-4.50337,"median":-3.720603,"eighty":-2.836115,"marketCap":969756923},{"date":"2021-11-12","current":250.504017,"twenty":-4.492661,"median":-3.714145,"eighty":-2.767971,"marketCap":996504978},{"date":"2021-11-19","current":225.324489,"twenty":-4.480962,"median":-3.706852,"eighty":-2.716856,"marketCap":896340818},{"date":"2021-11-26","current":208.538138,"twenty":-4.480962,"median":-3.702346,"eighty":-2.673681,"marketCap":829564711},{"date":"2021-12-03","current":188.523641,"twenty":-4.480962,"median":-3.699858,"eighty":-2.645398,"marketCap":749947045},{"date":"2021-12-10","current":207.892509,"twenty":-4.480962,"median":-3.687712,"eighty":-2.594402,"marketCap":826996399},{"date":"2021-12-17","current":229.843891,"twenty":-4.480962,"median":-3.681489,"eighty":-2.55596,"marketCap":914319000},{"date":"2021-12-23","current":231.135149,"twenty":-4.480962,"median":-3.675884,"eighty":-2.518274,"marketCap":919455624},{"date":"2021-12-31","current":207.892509,"twenty":-4.480962,"median":-3.670231,"eighty":-2.488017,"marketCap":826996399},{"date":"2022-01-07","current":193.043044,"twenty":-4.478774,"median":-3.656664,"eighty":-2.484485,"marketCap":767925228},{"date":"2022-01-14","current":196.916817,"twenty":-4.478774,"median":-3.656664,"eighty":-2.460584,"marketCap":783335099},{"date":"2022-01-21","current":173.028548,"twenty":-4.478774,"median":-3.656664,"eighty":-2.442206,"marketCap":688307562},{"date":"2022-01-28","current":169.800403,"twenty":-4.476586,"median":-3.655673,"eighty":-2.416994,"marketCap":675466003},{"date":"2022-02-04","current":154.305309,"twenty":-4.476586,"median":-3.654546,"eighty":-2.368992,"marketCap":613826520},{"date":"2022-02-11","current":157.533454,"twenty":-4.476586,"median":-3.646266,"eighty":-2.309108,"marketCap":626668079},{"date":"2022-02-18","current":164.635372,"twenty":-4.473257,"median":-3.633585,"eighty":-2.287512,"marketCap":654919509},{"date":"2022-02-25","current":172.382919,"twenty":-4.472972,"median":-3.627385,"eighty":-2.273796,"marketCap":685739250},{"date":"2022-03-04","current":-31.276341,"twenty":-4.487372,"median":-3.624232,"eighty":-2.265661,"marketCap":748317732},{"date":"2022-03-11","current":-30.201553,"twenty":-4.515269,"median":-3.624232,"eighty":-2.265661,"marketCap":722602346},{"date":"2022-03-18","current":-31.813735,"twenty":-4.534668,"median":-3.624232,"eighty":-2.265661,"marketCap":761175425},{"date":"2022-03-25","current":-29.019285,"twenty":-4.545222,"median":-3.624232,"eighty":-2.265661,"marketCap":694315422},{"date":"2022-04-01","current":-27.622061,"twenty":-4.554265,"median":-3.624232,"eighty":-2.265661,"marketCap":660885420},{"date":"2022-04-08","current":-25.687441,"twenty":-4.583796,"median":-3.632439,"eighty":-2.265661,"marketCap":614597725},{"date":"2022-04-14","current":-25.150047,"twenty":-4.591972,"median":-3.639532,"eighty":-2.265661,"marketCap":601740032},{"date":"2022-04-22","current":-22.355598,"twenty":-4.602401,"median":-3.656664,"eighty":-2.265661,"marketCap":534880028},{"date":"2022-04-29","current":-20.898026,"twenty":-4.613626,"median":-3.662921,"eighty":-2.265661,"marketCap":500006178},{"date":"2022-05-06","current":-18.864705,"twenty":-4.627212,"median":-3.670231,"eighty":-2.265661,"marketCap":451356928},{"date":"2022-05-13","current":-23.781378,"twenty":-4.638718,"median":-3.674393,"eighty":-2.265661,"marketCap":441715308},{"date":"2022-05-20","current":-22.90599,"twenty":-4.670065,"median":-3.690098,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-05-27","current":-23.489582,"twenty":-4.693902,"median":-3.704311,"eighty":-2.265661,"marketCap":436295489},{"date":"2022-06-03","current":-24.510868,"twenty":-4.720153,"median":-3.714507,"eighty":-2.265661,"marketCap":455264858},{"date":"2022-06-10","current":-21.301111,"twenty":-4.748522,"median":-3.733485,"eighty":-2.265661,"marketCap":395646841},{"date":"2022-06-17","current":-22.90599,"twenty":-4.769115,"median":-3.74907,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-06-24","current":-28.934653,"twenty":-4.783709,"median":-3.750097,"eighty":-2.26134,"marketCap":537432248},{"date":"2022-07-01","current":-29.848379,"twenty":-4.814658,"median":-3.750097,"eighty":-2.26134,"marketCap":554403792},{"date":"2022-07-08","current":-41.269953,"twenty":-4.847014,"median":-3.750097,"eighty":-2.26134,"marketCap":766548101},{"date":"2022-07-15","current":-43.858843,"twenty":-4.889306,"median":-3.750097,"eighty":-2.26134,"marketCap":814634144},{"date":"2022-07-22","current":-40.508514,"twenty":-4.895841,"median":-3.750097,"eighty":-2.26134,"marketCap":752405147},{"date":"2022-07-29","current":-39.290213,"twenty":-4.909329,"median":-3.750097,"eighty":-2.26134,"marketCap":729776421},{"date":"2022-08-05","current":-40.356227,"twenty":-4.945769,"median":-3.750097,"eighty":-2.26134,"marketCap":749576556},{"date":"2022-08-12","current":45.998677,"twenty":-4.954877,"median":-3.740203,"eighty":-2.241781,"marketCap":840993818},{"date":"2022-08-19","current":43.210879,"twenty":-4.954877,"median":-3.718267,"eighty":-2.228928,"marketCap":790024496},{"date":"2022-08-26","current":41.352346,"twenty":-4.954877,"median":-3.706852,"eighty":-2.208814,"marketCap":756044948},{"date":"2022-09-02","current":39.803569,"twenty":-4.954877,"median":-3.693851,"eighty":-2.187438,"marketCap":727728658},{"date":"2022-09-09","current":41.662102,"twenty":-4.954877,"median":-3.677376,"eighty":-2.178074,"marketCap":761708206},{"date":"2022-09-16","current":36.241382,"twenty":-4.954877,"median":-3.663474,"eighty":-2.143769,"marketCap":662601190},{"date":"2022-09-23","current":32.98895,"twenty":-4.954877,"median":-3.652457,"eighty":-2.114419,"marketCap":603136981},{"date":"2022-09-30","current":31.749929,"twenty":-4.935664,"median":-3.633097,"eighty":-2.043977,"marketCap":580483949},{"date":"2022-10-07","current":41.507224,"twenty":-4.900526,"median":-3.619552,"eighty":-2.004987,"marketCap":758876577},{"date":"2022-10-14","current":37.790159,"twenty":-4.854232,"median":-3.602328,"eighty":-1.947842,"marketCap":690917480},{"date":"2022-10-21","current":40.887713,"twenty":-4.818365,"median":-3.587597,"eighty":-1.883135,"marketCap":747550061},{"date":"2022-10-28","current":39.493814,"twenty":-4.818365,"median":-3.577659,"eighty":-1.827749,"marketCap":722065400},{"date":"2022-11-04","current":37.790159,"twenty":-4.818365,"median":-3.57269,"eighty":-1.797631,"marketCap":690917480},{"date":"2022-11-11","current":-3.566927,"twenty":-4.818365,"median":-3.572342,"eighty":-1.787835,"marketCap":765077329},{"date":"2022-11-18","current":-4.348525,"twenty":-4.818365,"median":-3.575678,"eighty":-1.787835,"marketCap":932723756},{"date":"2022-11-25","current":-3.993253,"twenty":-4.818365,"median":-3.586647,"eighty":-1.787835,"marketCap":856520834},{"date":"2022-12-02","current":-4.220627,"twenty":-4.818365,"median":-3.595749,"eighty":-1.787835,"marketCap":905290704},{"date":"2022-12-09","current":-3.439029,"twenty":-4.818365,"median":-3.602328,"eighty":-1.787835,"marketCap":737644277},{"date":"2022-12-16","current":-3.396397,"twenty":-4.818365,"median":-3.609154,"eighty":-1.787835,"marketCap":728499927},{"date":"2022-12-23","current":-3.481662,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":746788628},{"date":"2022-12-30","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-06","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-13","current":-4.192205,"twenty":-4.818365,"median":-3.630887,"eighty":-1.787835,"marketCap":899194470},{"date":"2023-01-20","current":-3.836934,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":822991549},{"date":"2023-01-27","current":-3.737457,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":801654731},{"date":"2023-02-03","current":-3.652192,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":783366030},{"date":"2023-02-10","current":-3.154812,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":676681940},{"date":"2023-02-17","current":-3.112179,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":667537590},{"date":"2023-02-24","current":-2.813751,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":603527136},{"date":"2023-03-03","current":-2.78533,"twenty":-4.787082,"median":-3.623771,"eighty":-1.787835,"marketCap":597430902},{"date":"2023-03-10","current":-2.13163,"twenty":-4.761022,"median":-3.609154,"eighty":-1.787835,"marketCap":457217527},{"date":"2023-03-17","current":-2.568557,"twenty":-4.722497,"median":-3.595749,"eighty":-1.787835,"marketCap":565272567},{"date":"2023-03-24","current":-2.251264,"twenty":-4.720153,"median":-3.586647,"eighty":-1.787835,"marketCap":495444779},{"date":"2023-03-31","current":-2.296592,"twenty":-4.720153,"median":-3.576669,"eighty":-1.787835,"marketCap":505420178},{"date":"2023-04-06","current":-2.190828,"twenty":-4.720153,"median":-3.573126,"eighty":-1.787835,"marketCap":482144248},{"date":"2023-04-14","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-04-21","current":-2.538338,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":558622302},{"date":"2023-04-28","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-05-05","current":-2.375309,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":522743683},{"date":"2023-05-12","current":-1.990022,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":478327553},{"date":"2023-05-18","current":-2.136839,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":512847659},{"date":"2023-05-26","current":-2.049621,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":491915102},{"date":"2023-06-02","current":-2.311274,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":554712774},{"date":"2023-06-08","current":-2.732828,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":655886802},{"date":"2023-06-16","current":-2.631073,"twenty":-4.720153,"median":-3.570015,"eighty":-1.787835,"marketCap":631465485},{"date":"2023-06-23","current":-2.587464,"twenty":-4.720153,"median":-3.572309,"eighty":-1.812326,"marketCap":620999207},{"date":"2023-06-30","current":-2.427565,"twenty":-4.720153,"median":-3.572309,"eighty":-1.898861,"marketCap":582622851},{"date":"2023-07-07","current":-2.282202,"twenty":-4.720153,"median":-3.572325,"eighty":-1.952741,"marketCap":547735255},{"date":"2023-07-14","current":-2.689219,"twenty":-4.720153,"median":-3.572342,"eighty":-1.990022,"marketCap":645420524},{"date":"2023-07-21","current":-2.383956,"twenty":-4.721325,"median":-3.572516,"eighty":-2.032983,"marketCap":572156572},{"date":"2023-07-28","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.049401,"marketCap":505870140},{"date":"2023-08-04","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":505870140},{"date":"2023-08-11","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-18","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-25","current":-1.922536,"twenty":-4.722497,"median":-3.57269,"eighty":-2.122302,"marketCap":504831008},{"date":"2023-09-01","current":-1.994812,"twenty":-4.72367,"median":-3.573126,"eighty":-2.122302,"marketCap":523809618},{"date":"2023-09-06","current":-1.85026,"twenty":-4.724842,"median":-3.573563,"eighty":-2.122823,"marketCap":485852399},{"date":"2023-09-15","current":-1.87917,"twenty":-4.730669,"median":-3.575678,"eighty":-2.125954,"marketCap":493443843},{"date":"2023-09-21","current":-1.734619,"twenty":-4.735324,"median":-3.575678,"eighty":-2.126721,"marketCap":455486624},{"date":"2023-09-27","current":-1.662343,"twenty":-4.744635,"median":-3.575678,"eighty":-2.131737,"marketCap":436508015},{"date":"2023-10-05","current":-1.459971,"twenty":-4.751199,"median":-3.576669,"eighty":-2.134128,"marketCap":383367908},{"date":"2023-10-13","current":-1.474426,"twenty":-4.755016,"median":-3.579398,"eighty":-2.135507,"marketCap":387163630},{"date":"2023-10-20","current":-1.392032,"twenty":-4.756925,"median":-3.581138,"eighty":-2.137245,"marketCap":365528016},{"date":"2023-10-27","current":-1.170868,"twenty":-4.758834,"median":-3.584493,"eighty":-2.147035,"marketCap":307453471},{"date":"2023-11-03","current":-1.228688,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":322636358},{"date":"2023-11-10","current":-1.049912,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":285969685},{"date":"2023-11-17","current":-0.987001,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":267046829},{"date":"2023-11-24","current":-0.97276,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":263193725},{"date":"2023-12-01","current":-1.095712,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":296460130},{"date":"2023-12-08","current":-1.142806,"twenty":-4.758834,"median":-3.584493,"eighty":-2.143769,"marketCap":309202079},{"date":"2023-12-15","current":-1.073293,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":290394352},{"date":"2023-12-22","current":-1.096417,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":296650878},{"date":"2023-12-29","current":-1.142101,"twenty":-4.758834,"median":-3.584493,"eighty":-2.135507,"marketCap":309011331},{"date":"2024-01-05","current":-1.095148,"twenty":-4.758834,"median":-3.58557,"eighty":-2.134619,"marketCap":296307532},{"date":"2024-01-12","current":-1.007446,"twenty":-4.758834,"median":-3.58557,"eighty":-2.125169,"marketCap":272578514},{"date":"2024-01-19","current":-0.794394,"twenty":-4.758834,"median":-3.586647,"eighty":-2.107766,"marketCap":214934548},{"date":"2024-01-26","current":-0.845719,"twenty":-4.758834,"median":-3.58557,"eighty":-2.075999,"marketCap":228820983},{"date":"2024-02-02","current":-0.895633,"twenty":-4.758834,"median":-3.58557,"eighty":-2.035084,"marketCap":242325923},{"date":"2024-02-09","current":-0.983194,"twenty":-4.758834,"median":-3.58557,"eighty":-1.99098,"marketCap":266016791},{"date":"2024-02-16","current":-0.964752,"twenty":-4.758834,"median":-3.58557,"eighty":-1.939882,"marketCap":261027212},{"date":"2024-02-23","current":-0.996035,"twenty":-4.758834,"median":-3.58557,"eighty":-1.896517,"marketCap":269491233},{"date":"2024-03-01","current":-0.988965,"twenty":-4.758834,"median":-3.584493,"eighty":-1.85026,"marketCap":267578233},{"date":"2024-03-08","current":-1.035018,"twenty":-4.758834,"median":-3.584493,"eighty":-1.792843,"marketCap":280038593},{"date":"2024-03-15","current":-0.975875,"twenty":-4.758834,"median":-3.584493,"eighty":-1.65367,"marketCap":251226366},{"date":"2024-03-22","current":-0.958317,"twenty":-4.758834,"median":-3.584493,"eighty":-1.538029,"marketCap":235516863},{"date":"2024-03-28","current":-0.94843,"twenty":-4.758834,"median":-3.584493,"eighty":-1.484545,"marketCap":233087127},{"date":"2024-04-05","current":-0.862349,"twenty":-4.758834,"median":-3.58557,"eighty":-1.295732,"marketCap":211931663},{"date":"2024-04-12","current":-0.755983,"twenty":-4.758834,"median":-3.58557,"eighty":-1.171601,"marketCap":185791046},{"date":"2024-04-19","current":-0.423589,"twenty":-4.758834,"median":-3.58557,"eighty":-1.150283,"marketCap":104101634},{"date":"2024-04-26","current":-0.707402,"twenty":-4.758834,"median":-3.584493,"eighty":-1.141509,"marketCap":173851824},{"date":"2024-05-03","current":-1.069542,"twenty":-4.758834,"median":-3.584493,"eighty":-1.12724,"marketCap":262851728},{"date":"2024-05-10","current":-1.028064,"twenty":-4.758834,"median":-3.584493,"eighty":-1.10327,"marketCap":246111338},{"date":"2024-05-17","current":-0.921047,"twenty":-4.758834,"median":-3.575678,"eighty":-1.095374,"marketCap":220492240},{"date":"2024-05-24","current":-1.083327,"twenty":-4.758834,"median":-3.572309,"eighty":-1.076226,"marketCap":259340873},{"date":"2024-05-31","current":-1.325431,"twenty":-4.758834,"median":-3.56471,"eighty":-1.076226,"marketCap":317298833},{"date":"2024-06-07","current":-1.452623,"twenty":-4.758834,"median":-3.552584,"eighty":-1.076226,"marketCap":347747762},{"date":"2024-06-14","current":-1.4035,"twenty":-4.758834,"median":-3.542773,"eighty":-1.074759,"marketCap":335988176},{"date":"2024-06-21","current":-1.190344,"twenty":-4.758834,"median":-3.537907,"eighty":-1.073293,"marketCap":284959971},{"date":"2024-06-28","current":-1.238589,"twenty":-4.762116,"median":-3.528963,"eighty":-1.072785,"marketCap":296509565},{"date":"2024-07-05","current":-1.274554,"twenty":-4.762116,"median":-3.51515,"eighty":-1.072785,"marketCap":305119262},{"date":"2024-07-12","current":-1.349992,"twenty":-4.762116,"median":-3.508598,"eighty":-1.072785,"marketCap":323178626},{"date":"2024-07-15","current":-1.368413,"twenty":-4.762116,"median":-3.503383,"eighty":-1.072785,"marketCap":327588471},{"date":"2024-08-02","current":-0.523681,"twenty":-4.777562,"median":-3.481662,"eighty":-1.070617,"marketCap":125365588},{"date":"2024-08-09","current":-0.509715,"twenty":-4.777562,"median":-3.475136,"eighty":-1.052035,"marketCap":113899848},{"date":"2024-08-16","current":-0.499096,"twenty":-4.777562,"median":-3.475136,"eighty":-1.0353,"marketCap":111526934},{"date":"2024-08-23","current":-0.528057,"twenty":-4.777562,"median":-3.467451,"eighty":-1.011394,"marketCap":117998517},{"date":"2024-08-30","current":-0.481719,"twenty":-4.777562,"median":-3.467451,"eighty":-1.002749,"marketCap":107643985},{"date":"2024-09-06","current":-0.482684,"twenty":-4.777562,"median":-3.465995,"eighty":-0.993799,"marketCap":107859705},{"date":"2024-09-13","current":-0.572464,"twenty":-4.777562,"median":-3.432608,"eighty":-0.988904,"marketCap":127921610},{"date":"2024-09-20","current":-0.578256,"twenty":-4.777562,"median":-3.410608,"eighty":-0.985676,"marketCap":129215926},{"date":"2024-09-27","current":-0.499096,"twenty":-4.777562,"median":-3.383717,"eighty":-0.975109,"marketCap":111526934},{"date":"2024-10-04","current":-0.440208,"twenty":-4.777562,"median":-3.383717,"eighty":-0.972752,"marketCap":98368050},{"date":"2024-10-11","current":-0.410282,"twenty":-4.777562,"median":-3.383717,"eighty":-0.959969,"marketCap":91680749},{"date":"2024-10-18","current":-0.441174,"twenty":-4.777562,"median":-3.383717,"eighty":-0.952469,"marketCap":98583770},{"date":"2024-10-25","current":-0.425728,"twenty":-4.777562,"median":-3.383717,"eighty":-0.940321,"marketCap":95132259},{"date":"2024-10-31","current":-0.423797,"twenty":-4.777562,"median":-3.383717,"eighty":-0.930994,"marketCap":94700820},{"date":"2024-11-08","current":-0.37939,"twenty":-4.777562,"median":-3.374713,"eighty":-0.91572,"marketCap":84777728},{"date":"2024-11-15","current":-0.285452,"twenty":-4.777562,"median":-3.303677,"eighty":-0.897325,"marketCap":64981233},{"date":"2024-11-22","current":-0.294727,"twenty":-4.761022,"median":-3.28271,"eighty":-0.869324,"marketCap":67092536},{"date":"2024-11-29","current":-0.352436,"twenty":-4.761022,"median":-3.252725,"eighty":-0.844647,"marketCap":80229537},{"date":"2024-12-06","current":-0.323581,"twenty":-4.761022,"median":-3.219896,"eighty":-0.822086,"marketCap":73661037},{"date":"2024-12-13","current":-0.317398,"twenty":-4.761022,"median":-3.168467,"eighty":-0.736551,"marketCap":72253501},{"date":"2024-12-20","current":-0.284422,"twenty":-4.761022,"median":-3.145635,"eighty":-0.595633,"marketCap":64746644},{"date":"2024-12-27","current":-0.289574,"twenty":-4.761022,"median":-3.106339,"eighty":-0.570147,"marketCap":65919590},{"date":"2025-01-03","current":-0.318429,"twenty":-4.761022,"median":-3.077193,"eighty":-0.552626,"marketCap":72488090},{"date":"2025-01-10","current":-0.350375,"twenty":-4.762116,"median":-3.05033,"eighty":-0.532191,"marketCap":79760358},{"date":"2025-01-17","current":-0.324612,"twenty":-4.762116,"median":-3.026485,"eighty":-0.512032,"marketCap":73895626},{"date":"2025-01-24","current":-0.387473,"twenty":-4.762116,"median":-2.980497,"eighty":-0.499868,"marketCap":88205573},{"date":"2025-01-31","current":-0.364802,"twenty":-4.762116,"median":-2.925709,"eighty":-0.495234,"marketCap":83044608},{"date":"2025-02-07","current":-0.385412,"twenty":-4.762116,"median":-2.870595,"eighty":-0.491533,"marketCap":87736394},{"date":"2025-02-14","current":-0.36068,"twenty":-4.762116,"median":-2.79954,"eighty":-0.479402,"marketCap":82106251},{"date":"2025-02-21","current":-0.355527,"twenty":-4.758834,"median":-2.764976,"eighty":-0.472606,"marketCap":80933305},{"date":"2025-02-28","current":-0.294727,"twenty":-4.758834,"median":-2.732828,"eighty":-0.45783,"marketCap":67092536},{"date":"2025-03-07","current":-0.242171,"twenty":-4.758834,"median":-2.711023,"eighty":-0.44909,"marketCap":55128483},{"date":"2025-03-14","current":-0.172611,"twenty":-4.758834,"median":-2.681951,"eighty":-0.441367,"marketCap":39293706},{"date":"2025-03-21","current":-0.186019,"twenty":-4.758834,"median":-2.616264,"eighty":-0.433644,"marketCap":42265764},{"date":"2025-03-28","current":-0.184905,"twenty":-4.758834,"median":-2.568557,"eighty":-0.424183,"marketCap":42012676},{"date":"2025-04-04","current":-0.178222,"twenty":-4.758834,"median":-2.531287,"eighty":-0.402997,"marketCap":40494145},{"date":"2025-04-11","current":-0.18045,"twenty":-4.758834,"median":-2.488661,"eighty":-0.391222,"marketCap":41000322},{"date":"2025-04-17","current":-0.183791,"twenty":-4.758834,"median":-2.484485,"eighty":-0.381387,"marketCap":41759587},{"date":"2025-04-25","current":-0.314116,"twenty":-4.758834,"median":-2.475296,"eighty":-0.371191,"marketCap":71370931},{"date":"2025-05-02","current":-0.318572,"twenty":-4.758834,"median":-2.439755,"eighty":-0.365832,"marketCap":72383285},{"date":"2025-05-09","current":-0.363545,"twenty":-4.758834,"median":-2.385601,"eighty":-0.36171,"marketCap":82601840},{"date":"2025-05-16","current":-0.486216,"twenty":-4.758834,"median":-2.379633,"eighty":-0.360886,"marketCap":92668953},{"date":"2025-05-23","current":-0.545195,"twenty":-4.758834,"median":-2.349838,"eighty":-0.360886,"marketCap":103909861},{"date":"2025-05-30","current":-0.460323,"twenty":-4.758834,"median":-2.31951,"eighty":-0.360886,"marketCap":87733920},{"date":"2025-06-06","current":-0.742271,"twenty":-4.758834,"median":-2.289397,"eighty":-0.360886,"marketCap":141470946},{"date":"2025-06-13","current":-0.693362,"twenty":-4.758834,"median":-2.263235,"eighty":-0.360886,"marketCap":132149217},{"date":"2025-06-20","current":-0.643014,"twenty":-4.758834,"median":-2.236155,"eighty":-0.36068,"marketCap":122553319},{"date":"2025-06-27","current":-0.706308,"twenty":-4.758834,"median":-2.20952,"eighty":-0.36068,"marketCap":134616733},{"date":"2025-07-03","current":-0.873176,"twenty":-4.758834,"median":-2.189024,"eighty":-0.36068,"marketCap":166420279},{"date":"2025-07-11","current":-0.851598,"twenty":-4.758834,"median":-2.160595,"eighty":-0.36068,"marketCap":162307752},{"date":"2025-07-18","current":-0.966679,"twenty":-4.758834,"median":-2.122302,"eighty":-0.36068,"marketCap":184241232},{"date":"2025-07-25","current":-0.86886,"twenty":-4.758834,"median":-2.107766,"eighty":-0.36068,"marketCap":165597774},{"date":"2025-08-01","current":-0.794058,"twenty":-4.758834,"median":-2.052632,"eighty":-0.36068,"marketCap":151341012},{"date":"2025-08-08","current":-0.684731,"twenty":-4.758834,"median":-2.01845,"eighty":-0.36068,"marketCap":130504206},{"date":"2025-08-15","current":-0.876202,"twenty":-4.758834,"median":-1.9793,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-08-22","current":-0.880054,"twenty":-4.758834,"median":-1.908081,"eighty":-0.36068,"marketCap":145618973},{"date":"2025-08-29","current":-0.818431,"twenty":-4.758834,"median":-1.85026,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-09-05","current":-0.826134,"twenty":-4.751199,"median":-1.806895,"eighty":-0.36068,"marketCap":136697023},{"date":"2025-09-12","current":-0.912791,"twenty":-4.720153,"median":-1.763529,"eighty":-0.36068,"marketCap":151035871},{"date":"2025-09-19","current":-0.876202,"twenty":-4.639607,"median":-1.590067,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-09-26","current":-0.751031,"twenty":-4.603027,"median":-1.532247,"eighty":-0.36068,"marketCap":124270021},{"date":"2025-10-03","current":-0.758733,"twenty":-4.603027,"median":-1.488588,"eighty":-0.36068,"marketCap":125544585},{"date":"2025-10-10","current":-0.818431,"twenty":-4.584765,"median":-1.469289,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-10-17","current":-0.768362,"twenty":-4.529097,"median":-1.4035,"eighty":-0.36068,"marketCap":127137790},{"date":"2025-10-24","current":-0.804951,"twenty":-4.504844,"median":-1.364904,"eighty":-0.36068,"marketCap":133191971},{"date":"2025-10-31","current":-0.733699,"twenty":-4.504844,"median":-1.327185,"eighty":-0.36068,"marketCap":121402251},{"date":"2025-11-07","current":-0.739476,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":122358174},{"date":"2025-11-14","current":-3.923437,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":137971587},{"date":"2025-11-21","current":-4.148775,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":145895817},{"date":"2025-11-28","current":-4.409887,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":155078071},{"date":"2025-12-05","current":-3.926346,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138073896},{"date":"2025-12-12","current":-3.945688,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138754063},{"date":"2025-12-19","current":-3.394452,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":119369304},{"date":"2025-12-26","current":-3.239719,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":113927969},{"date":"2026-01-02","current":-3.036632,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":106786215},{"date":"2026-01-09","current":-3.626551,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":127531308},{"date":"2026-01-16","current":-3.558856,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":125150724},{"date":"2026-01-23","current":-3.268732,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":114948219},{"date":"2026-01-30","current":-2.89157,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":101684963},{"date":"2026-02-06","current":-2.678813,"twenty":-4.430404,"median":-1.274554,"eighty":-0.36068,"marketCap":94203126},{"date":"2026-02-13","current":-2.756179,"twenty":-4.343462,"median":-1.274554,"eighty":-0.36068,"marketCap":96923794},{"date":"2026-02-20","current":-3.104328,"twenty":-4.263259,"median":-1.274554,"eighty":-0.36068,"marketCap":109166800},{"date":"2026-02-27","current":-3.24939,"twenty":-4.192205,"median":-1.274554,"eighty":-0.36068,"marketCap":114268052},{"date":"2026-03-06","current":-2.823875,"twenty":-4.177787,"median":-1.274554,"eighty":-0.36068,"marketCap":99304379},{"date":"2026-03-13","current":-2.8819,"twenty":-4.177787,"median":-1.274554,"eighty":-0.36068,"marketCap":101344880},{"date":"2026-03-20","current":1272.154157,"twenty":-4.177787,"median":-1.228688,"eighty":-0.36068,"marketCap":146297728},{"date":"2026-03-27","current":1148.611626,"twenty":-4.177787,"median":-1.174531,"eighty":-0.355527,"marketCap":132090337},{"date":"2026-04-02","current":1135.255678,"twenty":-4.177787,"median":-1.156906,"eighty":-0.352436,"marketCap":130554403},{"date":"2026-04-10","current":1485.849348,"twenty":-4.177787,"median":-1.142806,"eighty":-0.347999,"marketCap":170872675},{"date":"2026-04-17","current":1549.290104,"twenty":-4.177787,"median":-1.132758,"eighty":-0.342131,"marketCap":178168362}],"updateTime":1776586982689},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGEN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628638782","title":"Agenus reports Phase 2 results from BOT and BAL with agenT-797","url":"https://stock-news.laohu8.com/highlight/detail?id=2628638782","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628638782?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:51","pubTimestamp":1776459062,"startTime":"0","endTime":"0","summary":"Agenus (AGEN) announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating botensilimab (B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-reports-phase-2-results-from-bot-and-bal-with-agent-797-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-reports-phase-2-results-from-bot-and-bal-with-agent-797-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BAL","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628784758","title":"BRIEF-Agenus Reports Phase Ii Data Demonstrating Immune Reprogramming And Durable Survival With Botensilimab, Balstilimab And Agent-797 In Pd-1 Refractory Gastroesophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628784758","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628784758?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:46","pubTimestamp":1776458764,"startTime":"0","endTime":"0","summary":"BRIEF-Agenus Reports Phase Ii Data Demonstrating Immune Reprogramming And Durable Survival With Botensilimab, Balstilimab And Agent-797 In Pd-1 Refractory Gastroesophageal CancerApril 17 (Reuters) - A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA2JKG77:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628378429","title":"Agenus reports Phase II data showing 77% disease control in PD-1 refractory gastroesophageal cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628378429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628378429?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:43","pubTimestamp":1776458613,"startTime":"0","endTime":"0","summary":"Agenus reported Phase II results from an investigator-initiated study testing botensilimab, balstilimab, agenT-797, ramucirumab, paclitaxel in advanced PD-1 refractory gastroesophageal adenocarcinoma.Study showed high rates of disease control, with a subset of patients showing durable survival beyond 20 months.Induction dosing strategy delivered better outcomes than starting full combination immediately, supporting a sequencing approach that could shape future development plans.Trial missed primary response endpoint, but durability signal supported further study of regimen in this hard-to-treat setting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Busines","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL8l2zyl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628842547","title":"Agenus Inc - Study Does Not Meet Primary Endpoint of Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2628842547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628842547?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:43","pubTimestamp":1776458580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA2JKG77:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624865299","title":"Agenus to present Phase II BOT+BAL plus agenT-797 data in PD-1 refractory GEC at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2624865299","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624865299?lang=en_us&edition=fundamental","pubTime":"2026-04-03 19:30","pubTimestamp":1775215825,"startTime":"0","endTime":"0","summary":"Agenus flagged new Phase II trial data in PD-1 refractory gastroesophageal cancer for future presentation at AACR 2026.Study evaluates botensilimab with balstilimab alongside MiNK Therapeutics’ allogeneic iNKT cell therapy agenT-797.Update targets checkpoint-inhibitor resistant disease, a setting where treatment options remain limited.Presentation scheduled for April 20, 2026, during AACR Annual Meeting in San Diego.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on April 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL4qCGV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624652967","title":"Agenus Announces Data From Phase Ii Study of BOT+Bal in Combination With Agent-797 in Pd-1 Refractory Gastroesophageal Cancer to Be Presented at Aacr 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624652967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624652967?lang=en_us&edition=fundamental","pubTime":"2026-04-03 19:30","pubTimestamp":1775215800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nTUA8Z6FYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624851312","title":"Agenus Says First Patient Enrolled in Phase 3 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2624851312","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624851312?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:09","pubTimestamp":1775045348,"startTime":"0","endTime":"0","summary":"Agenus  said Wednesday that the first patient has been enrolled in its phase 3 trial evaluating the immunotherapy combination of botensilimab plus balstilimab against standard care in patients with a type of colorectal cancer.The company said the trial, led by the Canadian Cancer Trials Group, spans Canada, France, Australia and New Zealand, with more than 100 sites participating.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624590068","title":"Agenus enrolls first patient in Phase 3 BATTMAN trial for BOT+BAL in MSS mCRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2624590068","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624590068?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043047,"startTime":"0","endTime":"0","summary":"Agenus enrolled first patient in global Phase 3 BATTMAN  trial testing botensilimab with balstilimab versus best supportive care in refractory, unresectable MSS or pMMR metastatic colorectal cancer.No results have been presented; trial will generate registrational data intended to support potential approval pathway for BOT+BAL in this setting.Study targets population that represents about 95% of metastatic colorectal cancer cases, addressing segment widely viewed as resistant to immunotherapy.BATTMAN plans to enroll about 830 patients across more than 100 sites in Canada, France, Australia, New Zealand.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6b2ZlX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624059022","title":"Agenus Announces First Patient Enrolled in Global Phase 3 Battman Trial of BOT+Bal Immunotherapy Combination in Mss or Pmmr Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2624059022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624059022?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUA2Q7XZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594025","title":"Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624594025?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:15","pubTimestamp":1775038556,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on Agenus and keeping the price target at $23.00. Emily Bodnar’s rating is based ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/agenus-strengthening-bot-bal-clinical-profile-and-capital-efficient-path-to-registration-underpin-positive-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/agenus-strengthening-bot-bal-clinical-profile-and-capital-efficient-path-to-registration-underpin-positive-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622891827","title":"Agenus to host stakeholder webcast on BOT+BAL immunotherapy program; Q&A to follow live session","url":"https://stock-news.laohu8.com/highlight/detail?id=2622891827","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622891827?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:57","pubTimestamp":1774558671,"startTime":"0","endTime":"0","summary":"Agenus will host a stakeholder webcast on March 31, 2026, at 4:30 p.m. ET.The webcast will cover updates on botensilimab and balstilimab and patient access programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL1mHD9b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622452857","title":"Agenus securities class action dismissed in full; Massachusetts federal court denies leave to amend","url":"https://stock-news.laohu8.com/highlight/detail?id=2622452857","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622452857?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:25","pubTimestamp":1774527929,"startTime":"0","endTime":"0","summary":"On March 24, 2026, a federal court in Massachusetts issued an order in a putative securities class action against Agenus and several executives.The case is Byron Olsen v. Agenus, et al., Civil Action No. 24-CV-12299-AK.The court granted the defendants’ motion to dismiss the amended complaint in full.The order also denied the plaintiff’s request for leave to amend.Named individual defendants include Garo Armen, Christine Klaskin, Steven O'Day, and Todd Yancey.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL1cSswj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620427179","title":"Mink Therapeutics names Melissa Orilall principal financial officer and Austin Charette principal accounting officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427179","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427179?lang=en_us&edition=fundamental","pubTime":"2026-03-20 05:22","pubTimestamp":1773955325,"startTime":"0","endTime":"0","summary":"Mink Therapeutics appointed Melissa Orilall as Principal Financial Officer, effective March 13, 2026.Orilall is Vice President, Global Financial Operations at Agenus and previously worked at Whitehead Institute for Biomedical Research and in corporate banking.Austin Charette was appointed Principal Accounting Officer, effective March 13, 2026.Charette is Senior Director, Financial Reporting and Compliance at Agenus and previously worked at Deloitte & Touche.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 19, 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6NqBZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620401833","title":"Agenus (AGEN) Q3 Profit Of US$63.9 Million Tests Longstanding Loss-Making Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2620401833","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620401833?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:22","pubTimestamp":1773786166,"startTime":"0","endTime":"0","summary":"Agenus (NasdaqCM:AGEN) has swung to a profit in Q3 FY 2025, reporting total revenue of US$30.2 million and EPS of US$2.00, with net income of US$63.9 million for the period. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 to US$26.8 million in Q4 2024 and then to US$30.2 million in Q3 2025, while EPS shifted from a loss of US$2.52 per share in Q2 2024 to a loss of US$2.00 in Q4 2024 and then to a profit of US$2.00 in Q3 2025, indicating a sharp turn in reported...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agen/agenus/news/agenus-agen-q3-profit-of-us639-million-tests-longstanding-lo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agen/agenus/news/agenus-agen-q3-profit-of-us639-million-tests-longstanding-lo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620403922","title":"Agenus to present preliminary BOT+BAL first-line MSS metastatic colorectal cancer data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403922","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403922?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:40","pubTimestamp":1773780025,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on March 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL79MDsX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620418564","title":"Agenus Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2620418564","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620418564?lang=en_us&edition=fundamental","pubTime":"2026-03-17 07:38","pubTimestamp":1773704289,"startTime":"0","endTime":"0","summary":"Agenus Inc reports results for the quarter ended December 31 - Earnings SummaryAgenus Inc AGEN.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended December 31, higher tha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL8N4042I0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619462226","title":"Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462226","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462226?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:25","pubTimestamp":1773674717,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on Agenus, retaining the price target of $23.00. Emily Bodnar has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/agenus-advancing-battman-phase-3-and-leveraging-zydus-partnership-to-strengthen-risk‑reward-profile-and-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/agenus-advancing-battman-phase-3-and-leveraging-zydus-partnership-to-strengthen-risk‑reward-profile-and-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619457794","title":"Agenus Q4 2025 other revenue rose 87.8% to USD 31.1 million as net loss totaled USD 10.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619457794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619457794?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:30","pubTimestamp":1773660631,"startTime":"0","endTime":"0","summary":"Agenus published a quarterly and annual earnings release reporting financial results for Q4 and FY 2025, including initial revenue from early access programs for botensilimab plus balstilimab . Pre-commercial product revenue was USD 3.2 million in Q4 2025 and USD 4.2 million in FY 2025, reflecting treatment supplied through France’s AAC program and paid named-patient programs. Other revenue, including non-cash royalty revenue, was USD 31.1 million in Q4 2025 and USD 110 million in FY 2025. Operating income was USD 14.4 million in Q4 2025, while FY 2025 operating loss was USD 20.2 million; net loss was USD 10.6 million in Q4 2025 and USD 3.1 million in FY 2025. The company said the BOT+BAL program entered Phase 3 evaluation in refractory MSS metastatic colorectal cancer and that Zydus paid USD 91 million in upfront capital in January 2026, with a USD 20 million contingent payment triggered in March 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbqyHJV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619345704","title":"Press Release: Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized","url":"https://stock-news.laohu8.com/highlight/detail?id=2619345704","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619345704?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:30","pubTimestamp":1773660600,"startTime":"0","endTime":"0","summary":"--  Early access programs expand globally: 200+ physician inquiries across. 30+ countries; $4.2M in initial program revenue recognized. --  CRC leads BOT+BAL clinical development: 42% two-year overall survival. and 21-month median overall survival in heavily pretreated. --  BATTMAN Phase 3 registrational trial underway: First global. --  France expands reimbursed AAC access: Metastatic ovarian cancer and. --  Zydus collaboration strengthens balance sheet and manufacturing. The BOT+BAL program entered global Phase 3 evaluation in refractory microsatellite-stable  metastatic colorectal cancer , expanded through regulatory-authorized early access pathways in multiple countries and recognized initial revenue associated with treatment supplied through these programs while preparing for potential future regulatory submissions in the United States and Europe.\"BOT+BAL is beginning to stand out for the reasons that matter most; patients with few options are actively seeking access, physicians a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619645914","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2619645914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619645914?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:00","pubTimestamp":1773655200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·KE Hldgs ADR                                    4Q       .11   6:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","ARX","CBUS","ABEO","CLLS","DRI","EVEX","BIOA","BZ","BGSI","DCGO","ANDG","FLY","AEBI","AGEN","AVR","ESLT","ARCO","CANG","ZTO","ACN","CAAP","BTM","DLO","ASO","ASRT","FDX","DRIO","ECOR","BRAG","BDTX","DERM","FIVE","BALY","FLD","ETON","CELC","AVAH","DOCU","BEKE","CRIS","CAL","CSIQ","ELDN","ALVO","CDNL","DLTR","EQPT","ATAT"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}